Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://www.rdinvesting.com/ and get exclusive access to our numerous stock reports and market updates.
CareFusion Corporation (NYSE: CFN) shares increased 1.05 percent to close at $35.64 a share Thursday. The stock traded between $35.10 and $35.85 on volume of 1.90 million shares traded. Analysts at Citigroup have recently increased its price target on the company to $42.00 from $37.00 Shares of CareFusion have gained approximately 25.0 percent year-to-date.
Find out more about CareFusion including full access to the free equity report at:
Semiconductor Manufacturing Int'l (NYSE: SMI) shares increased 1.97 percent to close at $3.63 a share Thursday. The stock traded between $3.61 and $3.69 on volume of 188,748 shares traded. Analysts at Bernstein have recently upgraded the company’s rating to "market perform". Shares of Semiconductor Manufacturing have gained approximately 42.0 percent year-to-date.
Find out more about Semiconductor Manufacturing including full access to the free equity report at:
Stemline Therapeutics Inc. (NASDAQ: STML) shares increased 3.90 percent to close at $35.20 a share Thursday. The stock traded between $35.01 and $38.38 on volume of 443,294 shares traded. Analysts at Jefferies have recently initiated coverage on the company with a "buy" rating and a price target of $60.00. Shares of Stemline Therapeutics have gained nearly 190.0 percent year-to-date.
Find out more about Stemline Therapeutics including full access to the free equity report at:
Teradata Corporation (NYSE: TDC) shares increased 1.61 percent to close at $59.87 a share Thursday. The stock traded between $58.48 and $60.29 on volume of 916,040 shares traded. Analysts at Longbow have recently initiated coverage on the company with a "neutral" rating. Shares of Teradata have fallen approximately 3.2 percent year-to-date.
Find out more about Teradata including full access to the free equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Research Driven Investing
Leave a comment...